Teachers Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$10.3M Buy
107,356
+232
+0.2% +$20.8K 0.01% 990
2018
Q4
$7.59M Hold
107,124
0.01% 1076
2018
Q3
$9.15M Buy
107,124
+76,426
+249% +$7.66M 0.01% 1116
2018
Q2
$3.56M Buy
30,698
+2,030
+7% +$203K ﹤0.01% 1612
2018
Q1
$2.32M Hold
28,668
﹤0.01% 1734
2017
Q4
$1.68M Buy
28,668
+825
+3% +$41.3K ﹤0.01% 1956
2017
Q3
$1.3M Hold
27,843
﹤0.01% 2090
2017
Q2
$1M Buy
27,843
+2,661
+11% +$85.1K ﹤0.01% 2234
2017
Q1
$776K Buy
25,182
+700
+3% +$21.8K ﹤0.01% 2314
2016
Q4
$820K Buy
24,482
+777
+3% +$22.3K ﹤0.01% 2282
2016
Q3
$631K Hold
23,705
﹤0.01% 2345
2016
Q2
$523K Sell
23,705
-38
-0.2% -$995 ﹤0.01% 2383
2016
Q1
$697K Hold
23,743
﹤0.01% 2164
2015
Q4
$784K Hold
23,743
﹤0.01% 2151
2015
Q3
$858K Buy
23,743
+550
+2% +$23.6K ﹤0.01% 2085
2015
Q2
$1.04M Buy
23,193
+8,615
+59% +$335K ﹤0.01% 2093
2015
Q1
$446K Buy
14,578
+438
+3% +$17K ﹤0.01% 2491
2014
Q4
$719K Hold
14,140
﹤0.01% 2223
2014
Q3
$560K Hold
14,140
﹤0.01% 2340
2014
Q2
$609K Buy
14,140
+8,284
+141% +$316K ﹤0.01% 2329
2014
Q1
$234K Buy
5,856
+1,290
+28% +$46.9K ﹤0.01% 2799
2013
Q4
$125K Hold
4,566
﹤0.01% 2993
2013
Q3
$105K Sell
4,566
-28
-0.6% -$535 ﹤0.01% 2996
2013
Q2
$81K Buy
+4,594
New +$89.6K ﹤0.01% 3011

Other funds holding ENTA

Teachers Advisors's ENTA Position: Q1 2019 in Review

Teachers Advisors increased its Enanta Pharmaceuticals (ENTA) stake by 0.22% in Q1 2019, buying an estimated $20.8K and bringing the position to 107,356 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #990.

Teachers Advisors first reported a position in ENTA in Q2 2013 and has held it in 24 quarters since. 195 funds tracked by Wall St. Rank hold ENTA as of Q1 2019.

  • Teachers Advisors held 107,356 shares of Enanta Pharmaceuticals worth $10.3M as of Q1 2019.
  • Teachers Advisors bought 232 Enanta Pharmaceuticals shares in Q1 2019, an estimated $20.8K.
  • Enanta Pharmaceuticals made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #990 holding.
  • Teachers Advisors first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • 195 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.